Ken Griffin Options Holdings

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
AMN
Amn Healthcare Services Inc

Healthcare
CALL
$1.58 Million
76.4K
Q2 2025
Added 23.86%
AMN
Amn Healthcare Services Inc

Healthcare
PUT
$1.46 Million
70.6K
Q2 2025
Added 23.86%
AMRX
Amneal Pharmaceuticals, Inc.

Healthcare
CALL
$835,000
103K
Q2 2025
Reduced 77.25%
AMRX
Amneal Pharmaceuticals, Inc.

Healthcare
PUT
$96,000
11.9K
Q2 2025
Reduced 77.25%
AMPH
Amphastar Pharmaceuticals, Inc.

Healthcare
CALL
$420,000
18.3K
Q2 2025
Added 6.03%
AMPH
Amphastar Pharmaceuticals, Inc.

Healthcare
PUT
$282,000
12.3K
Q2 2025
Added 6.03%
Amplify Commodity Trust
CALL
$0
22.6K
Q2 2025
Reduced 30.38%
Amplify Commodity Trust
PUT
$0
31.4K
Q2 2025
Reduced 30.38%
AMPY
Amplify Energy Corp.

Energy
CALL
$251,000
78.5K
Q2 2025
Added 23.69%
AMPY
Amplify Energy Corp.

Energy
PUT
$377,000
118K
Q2 2025
Added 23.69%
DIVO
Amplify ETF Tr Amplify Cwp Enh

ETFs
PUT
$323,000
7.6K
Q2 2025
Added 100.0%
Amplify ETF Tr
PUT
$0
18.5K
Q2 2025
Added 28.14%
BLOK
Amplify ETF Tr Trnsformational

ETFs
CALL
$2.37 Million
41.5K
Q2 2025
Added 48.19%
BLOK
Amplify ETF Tr Trnsformational

ETFs
PUT
$1.4 Million
24.6K
Q2 2025
Added 48.19%
Amplify ETF Tr
CALL
$0
762K
Q2 2025
Added 10.14%
Amplify ETF Tr
PUT
$0
610K
Q2 2025
Added 10.14%
Amplify ETF Tr
CALL
$0
18.7K
Q2 2025
Added 2571.43%
Amplify ETF Tr
CALL
$0
8.3K
Q2 2025
Reduced 51.01%
Amplify ETF Tr
PUT
$0
9.7K
Q2 2025
Reduced 51.01%
YYY
Amplify ETF Tr High Income ETF

ETFs
PUT
$122,000
10.5K
Q2 2025
Reduced 22.22%
SWAN
Amplify ETF Tr Blackswan Growt
CALL
$0
22.1K
Q2 2025
Added 439.02%
AMPL
Amplitude, Inc.

Technology
CALL
$1.71 Million
138K
Q2 2025
Added 14.74%
AMPL
Amplitude, Inc.

Technology
PUT
$1.3 Million
105K
Q2 2025
Added 14.74%
AMPX
Amprius Technologies, Inc.

Industrials
CALL
$143,000
34.1K
Q2 2025
Reduced 35.56%
AMPX
Amprius Technologies, Inc.

Industrials
PUT
$61,000
14.5K
Q2 2025
Reduced 35.56%
ASYS
Amtech Systems Inc

Technology
CALL
$81,000
18.3K
Q2 2025
Added 1563.64%
AMLX
Amylyx Pharmaceuticals, Inc.

Healthcare
CALL
$285,000
44.6K
Q2 2025
Added 60.43%
Anaptysbio Inc
CALL
$0
44.6K
Q2 2025
Added 78.9%
Anaptysbio Inc
PUT
$0
19.5K
Q2 2025
Added 78.9%
AVXL
Anavex Life Sciences Corp.

Healthcare
CALL
$2.71 Million
294K
Q2 2025
Reduced 13.56%
AVXL
Anavex Life Sciences Corp.

Healthcare
PUT
$299,000
32.5K
Q2 2025
Reduced 13.56%
ANDE
Andersons, Inc.

Consumer Defensive
CALL
$378,000
10.3K
Q2 2025
Added 75.0%
ANDE
Andersons, Inc.

Consumer Defensive
PUT
$694,000
18.9K
Q2 2025
Added 75.0%
Angi Inc
CALL
$0
34.1K
Q2 2025
Added 1301.02%
Angi Inc
PUT
$0
30.3K
Q2 2025
Added 1301.02%
ANGO
Angiodynamics Inc

Healthcare
CALL
$205,000
20.7K
Q2 2025
Added 37.06%
ANGO
Angiodynamics Inc

Healthcare
PUT
$194,000
19.6K
Q2 2025
Added 37.06%
Anglogold Ashanti PLC
CALL
$0
480K
Q2 2025
Added 79.75%
Anglogold Ashanti PLC
PUT
$0
873K
Q2 2025
Added 79.75%
ANIP
Ani Pharmaceuticals Inc

Healthcare
PUT
$495,000
7.6K
Q2 2025
Reduced 11.63%
ANIX
Anixa Biosciences Inc

Healthcare
CALL
$46,000
14.1K
Q2 2025
Reduced 48.29%
ANIX
Anixa Biosciences Inc

Healthcare
PUT
$39,000
12.1K
Q2 2025
Reduced 48.29%
Annaly Capital Management In
CALL
$0
850K
Q2 2025
Added 62.67%
Annaly Capital Management In
PUT
$0
898K
Q2 2025
Added 62.67%
ANNX
Annexon, Inc.

Healthcare
PUT
$86,000
36K
Q2 2025
Reduced 30.9%
ANVS
Annovis Bio, Inc.

Healthcare
CALL
$71,000
33K
Q2 2025
Reduced 55.8%
ANVS
Annovis Bio, Inc.

Healthcare
PUT
$73,000
33.9K
Q2 2025
Reduced 55.8%
ANSS
Ansys Inc

Technology
CALL
$878,000
2.5K
Q2 2025
Reduced 74.85%
ANSS
Ansys Inc

Technology
PUT
$1.51 Million
4.3K
Q2 2025
Reduced 74.85%
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 15,124
  • Current Value $550 Billion
  • Prior Value $509 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1,309 stocks
  • Additional Purchases 2,297 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,137 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email